A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...
Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...
Daily administration of a cheap, widely available, antibiotic (co-trimoxazole) as prophylaxis halves mortality in severely immunosuppressed HIV-infected adults starting treatment in Africa; with ...
A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...
Background. The impact of pre-exposure prophylaxis (PrEP) with antiretrovirals on breakthrough HIV or SHIV infection is not fully documented. We addressed the hypothesis that SHIV SF162P3 infection ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
CD4 tests are strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, the World Health Organization (WHO) has strongly recommended in its 2025 ...
Purpose: The rationale for recent changes in guidelines for the prevention of opportunistic infections (OIs) in HIV-infected persons is discussed. Summary: The epidemiology of AIDS has changed ...
Of the 38 million people worldwide living with HIV, approximately 700,000 are newly infected men, primarily via sexual transmission. Sexually transmitted HIV infections in exclusively heterosexual men ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback